SCOTUS Backs SEC’s Power in Landmark Decision, Boosting Generic Drugmakers and Curbing Patent Lawsuits
admin floriparesort.com – 05 June 2026 | In a significant ruling, SCOTUS backs SEC’s power to regulate and oversee the pharmaceutical industry, particularly in cases involving generic drugmakers and patent lawsuits.…